Major Clotrimazole
NDC 71205-438
Product Information
Major Clotrimazole is a OTC MONOGRAPH DRUG-approved product labeled by Proficient Rx Lp. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 71205-438 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 71205-438?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLOTRIMAZOLE (UNII: G07GZ97H65)
- CLOTRIMAZOLE (UNII: G07GZ97H65) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
- POLYSORBATE 60 (UNII: CAL22UVI4M)
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- OCTYLDODECANOL (UNII: 461N1O614Y)
- CETYL PALMITATE (UNII: 5ZA2S6B08X)
* Please review the full disclaimer at the bottom of this page.
Patient Education
Clotrimazole Topical
Topical clotrimazole is used to treat tinea corporis (ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Clotrimazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.
[Learn More]
* Please review the full disclaimer at the bottom of this page.